BTM-1086 is primarily utilized in pharmaceutical research and development, particularly for neurological and brain-related disorders such as Alzheimer's disease, Parkinson's disease, and other psychiatric conditions. It possesses properties that can improve neuronal cell function and reduce brain inflammation. Preliminary studies indicate its potential to enhance memory and learning abilities, offering benefits for developing treatments for neurodegenerative diseases. Researchers explore its efficacy in preclinical studies as a drug candidate and use it in biochemical assays to understand interactions with cellular components, advancing novel therapies.